Christopher G. Isenberg serves as Executive at Halyard Health, Inc., where they oversee executive responsibilities. Since joining the company, Christopher G. Isenberg has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 30, 2017 involved selling 1,143 shares valued at $45.1K.
Christopher G. Isenberg currently holds 7,274 shares of Halyard Health, Inc. (HYH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher G. Isenberg has been a net neutral trader of HYH stock. They have purchased $0 and sold $0 worth of shares.
Christopher G. Isenberg's most recent insider trade was on Apr 30, 2017, when they sold 1,143 shares at $39.50 per share.
Get notified when new Form 4 filings are submitted
| $28.16 |
| Discretionary |
| May 1, 2016 | HYH | $22.4K | Payment | 795 | $28.16 | Discretionary |
| May 2, 2015 | HYH | $20.4K | Payment | 417 | $48.85 | Discretionary |
| Nov 7, 2014 | HYH | $0 | Award | 1,248 | $N/A | Discretionary |
| Nov 7, 2014 | HYH | $0 | Award | 2,079 | $N/A | Discretionary |
| Nov 7, 2014 | HYH | $0 | Award | 2,449 | $N/A | Discretionary |
| Nov 7, 2014 | HYH | $0 | Award | 3,426 | $N/A | Discretionary |